A Study of 177Lu-PSMA-617 in People With Gliomas

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Glioma · Diffuse Astrocytoma, IDH-Wildtype (Grade 2-4) · Glioblastoma, IDH-wildtype · Diffuse Midline Glioma, H3 K27-Altered · Diffuse Hemispheric Glioma, H3 G34-mutant · Diffuse Pediatric-type High-grade Glioma, H3-wildtype and IDH-wildtype

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Brandon Imber, MD) · 631-212-6346
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Brandon Imber, MD) · 631-212-6346
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Brandon Imber, MD) · 631-212-6346
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Brandon Imber, MD) · 631-212-6346
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Brandon Imber, MD) · 631-212-6346
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Brandon Imber, MD) · 631-212-6346
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Brandon Imber, MD) · 631-212-6346
מובילי המחקר
  • Brandon Imber, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center